AAV-mediated gene targeting methods for human cells

Nature Protocols

Volumn 6, Issue 4, 2011, Pages 482-501

  Khan, Iram F ^a   Hirata, Roli K ^a   Russell, David W ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENO ASSOCIATED VIRUS; ANIMAL; ARTICLE; CELL CULTURE; GENE TARGETING; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HUMAN; METHODOLOGY; MOUSE;

ANIMALS; CELLS, CULTURED; DEPENDOVIRUS; GENE TARGETING; GENETIC VECTORS; HUMANS; MICE; TRANSDUCTION, GENETIC;

EID: 79960046970     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2011.301     Document Type: Article

References (65)

1. Deng, C., Capecchi, M.R., Reexamination of gene targeting frequency as a function of the extent of homology between the targeting vector and the target locus. Mol. Cell. Biol. 12, 3365-3371 (1992).
2. Smithies, O., Gregg, R.G., Boggs, S.S., Koralewski, M.A., Kucherlapati, R.S., Insertion of DNA sequences into the human chromosomal beta-globin locus by homologous recombination. Nature 317, 230-234 (1985).
3. Thomas, K.R., Capecchi, M.R., Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51, 503-512 (1987).
4. Lombardo, A. et al. Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat. Biotechnol. 25, 1298-1306 (2007).
5. Zou, J. et al. Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell. Stem. Cell. 5, 97-110 (2009).
6. Hockemeyer, D. et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat. Biotechnol. 27, 851-857 (2009).
7. Cathomen, T., Joung, J.K., Zinc-finger nucleases: the next generation emerges. Mol. Ther. 16, 1200-1207 (2008).
8. Maeder, M.L. et al. Rapid ‘open-source’ engineering of customized zinc-finger nucleases for highly efficient gene modification. Mol. Cell 31, 294-301 (2008).
9. Inoue, N., Dong, R., Hirata, R.K., Russell, D.W., Introduction of single base substitutions at homologous chromosomal sequences by adeno-associated virus vectors. Mol. Ther. 3, 526-530 (2001).
10. Paiboonsukwong, K. et al. Correction of mutant Fanconi anemia gene by homologous recombination in human hematopoietic cells using adeno-associated virus vector. J. Gene. Med. 11, 1012-1019 (2009).
11. Samuels, Y. et al. Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell 7, 561-573 (2005).
12. Ericson, K. et al. Genetic inactivation of AKT1, AKT2, and PDPK1 in human colorectal cancer cells clarifies their roles in tumor growth regulation. Proc. Natl Acad. Sci. USA 107, 2598-2603 (2010).
13. Cummins, J.M. et al. Tumour suppression: disruption of HAUSP gene stabilizes p53. Nature 428, 1 p following 486 (2004).
14. Cummins, J.M. et al. X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cells. Cancer Res. 64, 3006-3008 (2004).
15. Chamberlain, J.R. et al. Gene targeting of mutant COL1A2 alleles in mesenchymal stem cells from individuals with osteogenesis imperfecta. Mol. Ther. 16, 187-193 (2008).
16. Chamberlain, J.R. et al. Gene targeting in stem cells from individuals with osteogenesis imperfecta. Science 303, 1198-1201 (2004).
17. Khan, I.F. et al. Engineering of human pluripotent stem cells by AAV-mediated gene targeting. Mol. Ther. 18, 1192-1199 (2010).
18. Mitsui, K. et al. Gene targeting in human pluripotent stem cells with adeno-associated virus vectors. Biochem. Biophys. Res. Commun. 388, 711-717 (2009).
19. Russell, D.W., Hirata, R.K., Human gene targeting by viral vectors. Nat. Genet. 18, 325-330 (1998).
20. Russell, D., Hirata, R., Human gene targeting favors insertions ove deletions. Hum. Gene. Ther. 19, 907-914 (2008).
21. Grim, J.E. et al. Isoform- and cell cycle-dependent substrate degradation by the Fbw7 ubiquitin ligase. J. Cell. Biol. 181, 913-920 (2008).
22. Topaloglu, O., Hurley, P.J., Yildirim, O., Civin, C.I., Bunz, F., Improved methods for the generation of human gene knockout and knockin cell lines. Nucleic Acids Res. 33, e158 (2005).
23. Hirata, R., Chamberlain, J., Dong, R., Russell, D.W., Targeted transgene insertion into human chromosomes by adeno-associated virus vectors. Nat. Biotechnol. 20, 735-738 (2002).
24. Kohli, M., Rago, C., Lengauer, C., Kinzler, K.W., Vogelstein, B., Facile methods for generating human somatic cell gene knockouts using recombinant adeno-associated viruses. Nucleic Acids Res. 32, e3 (2004).
25. Dang, L.H. et al. CDX2 has tumorigenic potential in the human colon cancer cell lines LOVO and SW48. Oncogene 25, 2264-2272 (2006).
26. Hurley, P.J., Wilsker, D., Bunz, F., Human cancer cells require ATR for cell cycle progression following exposure to ionizing radiation. Oncogene 26, 2535-2542 (2007).
27. Mocciaro, A. et al. Vertebrate cells genetically deficient for Cdc14A or Cdc14B retain DNA damage checkpoint proficiency but are impaired in DNA repair. J. Cell. Biol. 189, 631-639 (2010).
28. Wilsker, D., Petermann, E., Helleday, T., Bunz, F., Essential function of Chk1 can be uncoupled from DNA damage checkpoint and replication control. Proc. Natl. Acad. Sci. USA 105, 20752-20757 (2008).
29. Terret, M.E., Sherwood, R., Rahman, S., Qin, J., Jallepalli, P.V., Cohesin acetylation speeds the replication fork. Nature 462, 231-234 (2009).
30. Maciejowski, J. et al. Mps1 directs the assembly of Cdc20 inhibitory complexes during interphase and mitosis to control M phase timing and spindle checkpoint signaling. J. Cell. Biol. 190, 89-100 (2010).
31. Matsumoto, T. et al. Polo-like kinases mediate cell survival in mitochondrial dysfunction. Proc. Natl. Acad. Sci. USA 106, 14542-14546 (2009).
32. Petek, L.M., Fleckman, P., Miller, D.G., Efficient KRT14 targeting and functional characterization of transplanted human keratinocytes for the treatment of epidermolysis bullosa simplex. Mol. Ther. 18, 1624-1632 (2010).
33. Cunningham, S.C. et al. Targeted deletion of MKK4 in cancer cells: a detrimental phenotype manifests as decreased experimental metastasis and suggests a counterweight to the evolution of tumor-suppressor loss. Cancer Res. 66, 5560-5564 (2006).
34. Kim, J.S., Bonifant, C., Bunz, F., Lane, W.S., Waldman, T., Epitope tagging of endogenous genes in diverse human cell lines. Nucleic Acids Res. 36, e127 (2008).
35. Wang, Z., Epitope tagging of endogenous proteins for genome-wide chromatin immunoprecipitation analysis. Methods Mol. Biol. 567, 87-98 (2009).
36. Hirata, R.K., Russell, D.W., Design and packaging of adeno-associated virus gene targeting vectors. J. Virol. 74, 4612-4620 (2000).
37. Trobridge, G., Hirata, R.K., Russell, D.W., Gene targeting by adeno-associated virus vectors is cell-cycle dependent. Hum. Gene. Ther. 16, 522-526 (2005).
38. Sun, X. et al. Adeno-associated virus-targeted disruption of the CFTR gene in cloned ferrets. J. Clin. Invest. 118, 1578-1583 (2008).
39. Welsh, M.J., Rogers, C.S., Stoltz, D.A., Meyerholz, D.K., Prather, R.S. Development of a porcine model of cystic fibrosis. Trans. Am. Clin. Climatol. Assoc. 120, 149-162 (2009).
40. Miller, D.G. et al.Large-scale analysis of adeno-associated virus vector integration sites in normal human cells. J. Virol. 79, 11434-11442 (2005).
41. Song, K.Y., Schwartz, F., Maeda, N., Smithies, O., Kucherlapati, R., Accurate modification of a chromosomal plasmid by homologous recombination in human cells. Proc. Natl. Acad. Sci. USA 84, 6820-6824 (1987).
42. Sedivy, J.M., Sharp, P.A., Positive genetic selection for gene disruption in mammalian cells by homologous recombination. Proc. Natl. Acad. Sci. USA 86, 227-231 (1989).
43. Schwartzberg, P.L., Robertson, E.J., Goff, S.P., Targeted gene disruption of the endogenous c-abl locus by homologous recombination with DNA encoding a selectable fusion protein. Proc. Natl. Acad. Sci. USA 87, 3210-3214 (1990).
44. Marques, M.M., Thomson, A.J., McCreath, K.J., McWhir, J., Conventional gene targeting protocols lead to loss of targeted cells when applied to a silent gene locus in primary fibroblasts. J. Biotechnol. 125, 185-193 (2006).
45. Wong, E.A., Capecchi, M.R., Homologous recombination between coinjected DNA sequences peaks in early to mid-S phase. Mol. Cell. Biol. 7, 2294-2295 (1987).
46. Liu, X. et al. Targeted correction of single-base-pair mutations with adeno-associated virus vectors under nonselective conditions. J. Virol. 78, 4165-4175 (2004).
47. Sauer, B., Henderson, N., Cre-stimulated recombination at loxP-containing DNA sequences placed into the mammalian genome. Nucleic Acids Res. 17, 147-161, 1989
48. Miller, D.G. et al. Gene targeting in vivoby adeno-associated virus vectors. Nat. Biotechnol. 24, 1022-1026 (2006).
49. Inoue, N., Hirata, R.K., Russell, D.W., High-fidelity correction of mutations at multiple chromosomal positions by adeno-associated virus vectors. J. Virol. 73, 7376-7380 (1999).
50. Porteus, M.H., Cathomen, T., Weitzman, M.D., Baltimore, D., Efficient gene targeting mediated by adeno-associated virus and DNA double-strand breaks. Mol. Cell. Biol. 23, 3558-3565 (2003).
51. Gellhaus, K., Cornu, T.I., Heilbronn, R., Cathomen, T., Fate of recombinant adeno-associated viral vector genomes during DNA double-strand break-induced gene targeting in human cells. Hum. Gene. Ther. 21, 543-553 (2010).
52. te Riele, H., Maandag, E.R., Berns, A., Highly efficient gene targeting in embryonic stem cells through homologous recombination with isogenic DNA constructs. Proc. Natl. Acad. Sci. USA 89, 5128-5132 (1992).
53. Sedivy, J.M., Vogelstein, B., Liber, H.I., Hendrickson, E.A., Rosmarin, A., Gene targeting in human cells without isogenic DNA. Science 283, 9 (1999).
54. Grimm, D., Kern, A., Rittner, K., Kleinschmidt, J.A., Novel tools for production and purification of recombinant adenoassociated virus vectors. Hum. Gene. Ther. 9, 2745-2760 (1998).
55. Rutledge, E.A., Halbert, C.L., Russell, D.W., Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. J. Virol. 72, 309-319 (1998).
56. Grieger, J.C., Choi, V.W., Samulski, R.J., Production and characterization of adeno-associated viral vectors. Nat. Protoc. 1, 1412-1428 (2006).
57. Zolotukhin, S. et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene. Ther. 6, 973-985 (1999).
58. Gao, G., Vandenberghe, L.H., Wilson, J.M., New recombinant serotypes of AAV vectors. Curr. Gene. Ther. 5, 285-297 (2005).
59. Snyder, R.O., Xiao, X., Samulski, R.J., Production of recombinant adeno-associated viral vectors. In Current Protocols in Human Genetics (ed. Dracopoli, N.) 12.11.11-12.11.20 (John Wiley, 1996).
60. Inoue, N., Russell, D.W., Packaging cells based on inducible gene amplification for the production of adeno-associated virus vectors. J. Virol. 72, 7024-7031 (1998).
61. DuBridge, R.B. et al. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell. Biol. 7, 379-387 (1987).
62. Tucker, K.L., Wang, Y., Dausman, J., Jaenisch, R., A transgenic mouse strain expressing four drug-selectable marker genes. Nucleic Acids Res. 25, 3745-3746 (1997).
63. Chomczynski, P., One-hour downward alkaline capillary transfer for blotting of DNA and RNA. Anal. Biochem. 201, 134-139 (1992).
64. Ware, C.B., Nelson, A.M., Blau, C., A. Controlled-rate freezing of human ES cells. Biotechniques 38, 879-880, 882-873 (2005).
65. Rago, C., Vogelstein, B., Bunz, F., Genetic knockouts and knockins in human somatic cells. Nat. Protoc. 2, 2734-2746 (2007).